Join on WhatsApp
Join on Telegram
Agadir – Morocco’s House of Councillors Committee on Education and Cultural and Social Affairs approved a bill amending the country’s Code of Medicines and Pharmacy.
The committee adopted draft law No. 27.26 by majority vote on Monday in the presence of Health and Social Protection Minister Amine Tehraoui, notes a statement from the Ministry of Health and Social Protection.
According to the ministry, the bill seeks to align Morocco’s pharmaceutical regulatory framework with international standards and strengthen the role of the Moroccan Agency for Medicines and Health Products.
The proposed amendments would expand the agency’s responsibilities in “authorization, control, inspection, and pharmaceutical vigilance,” while supporting Morocco’s efforts to attain the World Health Organization’s regulatory maturity level 3 (ML3), the statement explained.
The ministry noted that the reform is intended to “support the evolution of the national pharmaceutical sector, strengthen the regulatory mechanisms for medicines and health products, and guarantee their quality, safety and effectiveness.”
Read also: Morocco’s Competition Council Calls for New Criteria to Rebalance Pharmacy Distribution
Among the key provisions, the bill introduces tighter regulation of certain health-related products, including food supplements that may require medical prescriptions because of their composition, dosage, or effects.
The legislation also seeks to bolster Morocco’s pharmaceutical vigilance system by formalizing its institutional and organizational framework and defining applicable good-practice standards.
It further strengthens the responsibility of pharmaceutical manufacturers in monitoring the safety of medicines after they reach the market.
The ministry said discussions within the committee underscored the importance of the reform in modernizing the legal framework governing pharmaceuticals, strengthening national pharmaceutical sovereignty, and consolidating Morocco’s position as “a more efficient, structured, and internationally aligned health regulatory system.”
The bill had previously secured approval from the House of Representatives’ Social Sectors Committee before being reviewed and adopted by the corresponding committee in the House of Councillors.
According to the ministry, the adoption of draft law No. 27.26 marks “an important step in the process of strengthening the governance of the medicines and health products sector” and ensuring citizens have access to medicines that meet quality, safety, and efficacy standards.
